In recent years, cell migration assays (CMAs) have emerged as a tool to study the migration of cells along with their physiological responses under various stimuli, including both mechanical and bio-chemical properties. CMAs are a generic system in that they support various biological applications, such as wound healing assays. In this paper, we review the development of the CMA in the context of its application to wound healing assays. As such, the wound healing assay will be used to derive the requirements on CMAs. This paper will provide a comprehensive and critical review of the development of CMAs along with their application to wound healing assays. One salient feature of our methodology in this paper is the application of the so-called design thinking; namely we define the requirements of CMAs first and then take them as a benchmark for various developments of CMAs in the literature. The state-of-the-art CMAs are compared with this benchmark to derive the knowledge and technological gap with CMAs in the literature. We will also discuss future research directions for the CMA together with its application to wound healing assays.
Cell migration refers to the directional movement of cells to the surrounding cell-free zone in response to chemical and mechanical stimuli. A cell migration assay is an essential device for studying pharmaceutical and medical problems. In this paper, we present a novel approach to a cell migration assay on a chip with two merits, namely (i) simultaneous creation of many cell samples on the same condition and (ii) cells migrating while being stressed in a fluidic environment. The first merit has addressed the problem of poor reproducibility in experimental studies for medical problems such as wound healing, and the second merit has made the cell migration device, which is an in vitro environment, more biomimetic. The two merits are attributed to a novel mechanical method to simultaneously create many cell-free zones and to the design of a microfluidic process to create shear stress in cells uniformly. Two applications were studied on our device to explore its effectiveness. The first application is regarding the combination chemotherapy of cisplatin and doxorubicin (Adriamycin) on cervical cancer cells (HeLa). The second application is regarding inhibiting the migration of endothelial cells (HUVEC) in the process of anti-angiogenesis.
26 August 2020 in Journal of Coordination Chemistry
Synthesis of catalysts with high activity for hydrogen evolution reaction (HER) has been a hot topic in electrocatalysis. In this paper, using MIL-88A(Fe) metal-organic complex, polyoxometalate (POM) and H2PtCl6 as starting materials, hierarchic and low Pt0-loading micro-rods (denoted as Pt-POMFe, i.e. Pt-PW12Fe or Pt-PMo12Fe) have been synthesized, in which the Pt0 nanoparticles can be stabilized by POM. The Pt-PW12Fe micro-rod containing [PW12O40]3- polyoxoanion component (0.30% Pt0-loading) which retains the spindle structure of its parent MIL-88A(Fe) exhibits a low overpotential of 28 mV at current density of 10 mA·cm−2 for HER that is close to the electrocatalytic effect of commercial Pt/C (ca. 20% Pt0-loading). Such high electrocatalytic reactivity is mainly caused by the synergistic effect of the three components of POM, Pt0, and Fe3O4@C. The structure effectively increases the active sites of the catalyst and improves its conductivity and stability. The Pt-POMFe catalyst extends a new family of MOF-POM functional materials and provides a new concept to the design and synthesis of highly-efficient and low-cost electrocatalyst for hydrogen production.
Crystallization is an important process in the pharmaceutical manufacturing industry. In this work, we report a study to create the zinc-free crystals of bovine insulin on a flow-free droplet-based platform we previously developed. The benefit of this platform is its promise to create a single type of crystals under a simpler and more stable environment and with a high throughput. The experimental result shows that the bovine insulin forms a rhombic dodecahedra shape and the coefficient variation (CV) in the size of crystals is less than 5%. These results are very promising for the insulin production.